Biopharma News

May 13, 2014
By BioPharm International Editors
KBI Biopharma acquires Merck's microbial process development and manufacturing operations in Colorado.
May 12, 2014
By BioPharm International Editors
Shire expands rare disease portfolio with acquisition of Lumena Pharmaceuticals.
May 09, 2014
By BioPharm International Editors
Boehringer Ingelheim and Connexios Life Sciences announce global research collaboration agreement for AMPK agonists.
May 09, 2014
By BioPharm International Editors
Cumberland Pharmaceuticals and Gloria Pharmaceuticals invest $1 million each in Cumberland Emerging Technologies.
Apr 30, 2014
By BioPharm International Editors
BMS acquisition of iPierian advances BMS' pursuit of therapeutics for genetically defined diseases.
Apr 30, 2014
By BioPharm International Editors
Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.
Apr 30, 2014
By BioPharm International Editors
Agenus and Merck work together to advance immune-oncology programs.
Apr 23, 2014
By BioPharm International Editors
Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.
Apr 22, 2014
By BioPharm International Editors
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Apr 21, 2014
By BioPharm International Editors
Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.
native1_300x100
lorem ipsum